anmelden
SLI
2.212,64
PKT
-3,09
PKT
-0,14
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.02.05 | Swiss Life Outperform | HypoVereinsbank | |
| 03.02.05 | Roche In-Line | Goldman Sachs | |
| 04.02.05 | Swiss Life Outperform | HypoVereinsbank | |
| 03.02.05 | Novartis Übergewichten | Reuschel & Co | |
| 02.02.05 | Roche Buy | Sarasin Research | |
| 02.02.05 | Swiss Life Overweight | JP Morgan | |
| 02.02.05 | Roche Halten | Helaba Trust | |
| 03.02.05 | Roche Buy | Sarasin Research | |
| 01.02.05 | UBS Buy | Sarasin Research | |
| 01.02.05 | Zurich Insurance Buy | Sarasin Research | |
| 01.02.05 | Novartis Kaufen | SYZ & CO | |
| 01.02.05 | Roche Halten | Helaba Trust | |
| 01.02.05 | UBS Buy | Merrill Lynch | |
| 01.02.05 | UBS Neutral | Merrill Lynch | |
| 01.02.05 | Logitech Kauf | SYZ & CO | |
| 31.01.05 | Roche Buy | Sarasin Research | |
| 02.02.05 | UBS Outperform | Credit Suisse First Boston | |
| 31.01.05 | Lonza Reduce | Sarasin Research | |
| 31.01.05 | Nestlé Neutral | Sarasin Research | |
| 31.01.05 | Novartis Outperform | Credit Suisse First Boston | |
| 01.02.05 | Roche Neutral | Credit Suisse First Boston | |
| 28.01.05 | Holcim Verkaufen | Helaba Trust | |
| 31.01.05 | Novartis Buy | Helvea | |
| 27.01.05 | Lonza Buy | Helvea | |
| 27.01.05 | Holcim Halten | Helaba Trust | |
| 03.02.05 | Novartis Outperformer | Sparkasse KölnBonn | |
| 27.01.05 | Holcim Neutral | Helvea | |
| 26.01.05 | Novartis Market Perform | William Blair | |
| 26.01.05 | Lindt In-Line | Goldman Sachs | |
| 26.01.05 | UBS Buy | Sarasin Research | |
| 26.01.05 | Lonza Reduce | Sarasin Research | |
| 26.01.05 | Lindt Neutral | Sarasin Research | |
| 26.01.05 | Nestlé Outperform | Credit Suisse First Boston | |
| 25.01.05 | Lonza Overweight | JP Morgan | |
| 25.01.05 | Lindt Neutral | Helvea | |
| 25.01.05 | Swisscom Underweight | Lehman Brothers | |
| 25.01.05 | UBS Buy | Helvea | |
| 25.01.05 | Holcim Accumulate | Helvea | |
| 25.01.05 | Novartis Outperform | Goldman Sachs | |
| 25.01.05 | Novartis Halten | LB Baden-Württemberg |